Achim Diedenhofen
Business Angel Investor and Healthcare Group Co-Coach @ GoBeyond
Zürich, Switzerland
Achim Diedenhofen is a venture - series unknown investor at GoBeyond in Zürich focused on Medical and Medical Device. Achim Diedenhofen - Business Angel Investor and Healthcare Group Co-Coach @ GoBeyond
- Total investments:
- 9
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Achim Diedenhofen invests in
Stages Achim Diedenhofen invests in
Countries Achim Diedenhofen invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 2 (22%)
- Medical Device 2 (22%)
- Dental 1 (11%)
- Hospital 1 (11%)
- Software 1 (11%)
Stage
- Venture - Series Unknown 3 (33%)
- Series B 2 (22%)
- Series A 1 (11%)
Country
- Switzerland 2 (22%)
- Denmark 1 (11%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| By combining modern Scandinavian bioengineering and medical device design with first-rate Taiwanese hardware, software and manufacturing engineering, BluSense has created a breakthrough diagnostics system for infectious diseases. | Series B / Apr 26, 2018 | ||
| Mininavident provides a handheld navigation system for the precise implantation of dental implants. The system is miniaturized and includes a tablet computer for real time visualization. It provides a seamless integration of 3D implant planning with the actual surgery. With its practicability and increased precision, the system supports not onlythe experienced surgeon but also the general practitioner in the broad field of dental implantology. | Venture - Series Unknown / Mar 28, 2018 | ||
| By combining modern Scandinavian bioengineering and medical device design with first-rate Taiwanese hardware, software and manufacturing engineering, BluSense has created a breakthrough diagnostics system for infectious diseases. | Series B / May 31, 2017 | ||
| Mininavident provides a handheld navigation system for the precise implantation of dental implants. The system is miniaturized and includes a tablet computer for real time visualization. It provides a seamless integration of 3D implant planning with the actual surgery. With its practicability and increased precision, the system supports not onlythe experienced surgeon but also the general practitioner in the broad field of dental implantology. | Venture - Series Unknown / Sep 29, 2016 | ||
| By combining modern Scandinavian bioengineering and medical device design with first-rate Taiwanese hardware, software and manufacturing engineering, BluSense has created a breakthrough diagnostics system for infectious diseases. | Venture - Series Unknown / Jul 16, 2016 | ||
| Mininavident provides a handheld navigation system for the precise implantation of dental implants. The system is miniaturized and includes a tablet computer for real time visualization. It provides a seamless integration of 3D implant planning with the actual surgery. With its practicability and increased precision, the system supports not onlythe experienced surgeon but also the general practitioner in the broad field of dental implantology. | Series B / Jan 11, 2016 | ||
| By combining modern Scandinavian bioengineering and medical device design with first-rate Taiwanese hardware, software and manufacturing engineering, BluSense has created a breakthrough diagnostics system for infectious diseases. | Series A / Aug 19, 2015 | ||
| Mininavident provides a handheld navigation system for the precise implantation of dental implants. The system is miniaturized and includes a tablet computer for real time visualization. It provides a seamless integration of 3D implant planning with the actual surgery. With its practicability and increased precision, the system supports not onlythe experienced surgeon but also the general practitioner in the broad field of dental implantology. | $1.4M / Series B / Mar 20, 2015 | ||
| Medirio provides insulin pen users with a new drug delivery system which allows diabetic patients to manage their insulin injections in an easier, discreet and more comfortable way. Their medical device is indeed designed to significantly improve both efficiency and therapy control, together with a fresh new user experience which eases andsimplifies the medication‑related action plan.The integrated insulin delivery system eliminates all of the complicating factors associated with insulin pens or syringes. They managed to develop a drug delivery system that is so small and lightweight. Medirio was founded in 2013 and is based in Sierre, Valais, Switzerland. | Venture - Series Unknown / Jan 28, 2015 |
Co-Investors
About GoBeyond
GoBeyond is a FinTech company transforming angel investing into a new scalable asset class for small and large, novice to experienced investors. It offers a unique deal platform, portfolio tools, syndication/pooling, due diligence, investment monitoring services, training and certified deal leaders.Its clients are individuals, familyoffices, professional groups and corporations. It is active in the EU, Switzerland and the US. GoBeyond also offers educational training modules for angel investors in 11 categories.
GoBeyond Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Patricia Dimond
Early Stage Investing Specialists
|
|||
|
Achim Diedenhofen
Business Angel Investor and Healthcare Group Co-Coach
|
|||
Alexander Manolov
Business Angel/Startup mentor
|
|||
Balz Roth
Venture Partner
|
|||
Bethann Kassman
CEO, Go Beyond Network
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Achim Diedenhofen invest in?
Achim Diedenhofen invests primarily in Medical, Medical Device and Dental startups, most often at Venture - Series Unknown and Series B stage. Most of the 9 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Achim Diedenhofen?
Public channels for Achim Diedenhofen include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Achim Diedenhofen last invest?
The most recent investment recorded for Achim Diedenhofen closed in Apr 2018. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
